SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (SEELQ)

Q: What does CUSIP 81577F406 represent in this 13F holders report?

CUSIP 81577F406 is the security identifier for SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2025?

No institutional holders were reported for SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2025; review adjacent reporting periods for trend context.

CUSIP: 81577F406

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 581,045
Total 13F shares: 0
Share change: -20,550
Total reported value: $0
Price per share: $0.30
Number of holders: 0
Value change: -$4,774
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 81577F406?
CUSIP 81577F406 identifies SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2024

Recent filing periods for CUSIP 81577F406:

Q1 2025 Q4 2024 Q3 2024

SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (SEELQ)

Q1 2025 13F Holders as of 31 Mar 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of SEELQ - SEELOS THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q1 2025.